ArticleCancers2025

Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014-2023).

Maria Antonietta Barbieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.